Related Experiment Video
Updated: Sep 3, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Progress in the pharmacotherapy of uveitis: the art of personalized care
Shivam H Patel1, Aditya Belamkar1, Amir R Hajrasouliha1
1Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA.
Introduction:
Uveitis is a heterogeneous group of inflammatory intraocular disorders that can lead to blindness, but prompt diagnosis and management can improve visual outcomes and reduce treatment burden.
Areas Covered:
In this review, the authors provide an overview of commonly used treatments for the management of noninfectious uveitis.
Expert Opinion:
Initially, the treatment of noninfectious uveitis was limited to corticosteroids, which have a broad range of adverse ocular and systemic effects. Now new delivery and therapeutic options, such as biological response modulators, represent novel yet exciting additions to this armory and have the potential to alter the course of treatment as well as prognostic outcomes for uveitis patients. Further research is needed to evaluate the efficacy of this novel class of immunomodulators in uveitis therapy.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Nephrotic Syndrome II : Assessment and Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

